Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8651815 | The American Journal of the Medical Sciences | 2018 | 27 Pages |
Abstract
HSC express iron-transport proteins. Holotransferrin (iron) activates HSC fibrogenesis and the TGF-β pathway, whereas iron depletion by chelation reverses this, suggesting that this could be a useful adjunct therapy for patients with fibrosis. Further studies in primary human HSC and animal models are necessary to confirm this.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Kosha J. PhD, Jason D. PhD, Marco PhD, Paul P. MD, Roger MD, Vinood B. PhD, Wing-Kin MD,